Simcere Pharmaceutical Group Limited — AGM Information 2023

May 24, 2023

==> picture [44 x 35] intentionally omitted <==

Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock code: 2096)

PROXY FORM FOR ANNUAL GENERAL MEETING

==> picture [595 x 354] intentionally omitted <==

----- Start of picture text ----- I/We [1]of(thebeing“the Shares registered”) of Simcereholder(s) Pharmaceuticalof Group Limited (先聲藥業集團有限公司) (the “ Company ”), HEREBY APPOINT THE CHAIRMAN OF THE MEETING2 shares [3] ,orof(who represents Shares held by me/us) [2] as my/our proxy to attend and act for me/us and on my/our behalf at the annual generalmeeting (the “ Meeting ”) of the Company to be held at No. 699-18, Xuanwu Road, Xuanwu District, Nanjing, Jiangsu, PRC on Thursday, June 15, 2023 at 9:00 a.m. or at any adjournmentthereof (as the case may be) for the purpose of considering and, if thought fit, passing the resolutions as set out in the notice convening the Meeting and at the Meeting or at anyadjournment thereof (as the case may be) to vote for me/us and in my/our name(s) in respect of such resolutions as hereunder indicated, and, if no such indication is given, as my/our proxythinks fit. My/our proxy will also be entitled to vote on any matter properly put to the Meeting in such manner as he/she thinks fit.ORDINARY RESOLUTIONS FOR [4] AGAINST [4]1. To receive, consider and adopt the audited consolidated financial statements of the Company and the reports of thedirectors of the Company (the “ Director(s) ”) and auditors of the Company (the “ Auditors ”) for the year ended December31, 2022.2. (a) To declare a final dividend of RMB0.16 per ordinary share of the Company (the “ Final Dividend ”) for the yearended December 31, 2022.(b) Any Director be and is hereby authorised to take such action, do such things and execute such further documents asthe Director may at his/her absolute discretion consider necessary or desirable for the purpose of or in connectionwith the implementation of the payment of the Final Dividend.3. (a) To re-elect the following retiring Directors:i. Mr. TANG Renhong as an executive Director;ii. Mr. WAN Yushan as an executive Director; andiii. Mr. WANG Xinhua as an independent non-executive Director.(b) To authorise the board of the Directors to fix the remuneration of the Directors.4. To re-appoint KPMG as the Auditors and authorise the board of the Directors to fix their remuneration.5. To grant a general mandate to the Directors to allot, issue and deal with the securities of the Company not exceeding 20%of the total number of shares of the Company in issue as at the date of the Meeting.6. To grant a general mandate to the Directors to repurchase the securities of the Company not exceeding 10% of the totalnumber of shares of the Company in issue as at the date of the Meeting.7. To extend, conditional upon the passing of resolutions 5 and 6, the total number of shares of the Company repurchasedunder resolution 6 to the mandate granted to the directors under resolution 5.8. (a) Subject to and conditional upon the Listing Committee of The Stock Exchange of Hong Kong Limited granting theapproval for the listing of, and the permission to deal in, shares of the Company to be allotted and issued in respectofMayawards20, 2021whichformayadoptionbe granted(the “ 2021 under RSU the restricted scheme ”),shareto approveunit schemeand adoptof thetheCompanyproposedapprovedamendmentsby thetoBoardthe 2021onRSU Scheme, and authorize the Board and the committee duly appointed by the Board for the purpose ofadministering the 2021 RSU Scheme to do all such acts and to enter into all such transactions, arrangements andagreements as may be necessary or expedient in order to give full effect to the 2021 RSU Scheme.(b) To approve that the total number of shares of the Company which may be issued in respect of all options and awardsto be granted under the 2021 RSU Scheme and any other share options schemes and/or share award schemesinvolving issuance of new Shares adopted and to be adopted by the Company from time to time must not in aggregateexceed 10% of the total number of shares of the Company in issue as at the date of passing of this resolution.----- End of picture text -----

• Signature[5] Date Notes: 1. Full name(s) and address(es) must be inserted in BLOCK CAPITALS . The names of all joint registered holders should be stated. 2. Please insert the number of Shares registered in your name(s) to which this proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all Shares registered in your name(s). 3. If any proxy other than the Chairman of the Meeting is preferred, strike out “the Chairman of the Meeting” and insert the name and address of the proxy desired in the space provided. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT .

• 1. IMPORTANT: If you wish to vote for a resolution, tick in the box marked “For”. If you wish to vote against a resolution, tick in the box marked “Against”. If no direction is given, your proxy may vote or abstain as he/she thinks fit . Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the Meeting other than referred to the notice convening the Meeting.
• 1. This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a corporation, must be either under its common seal or under the hand of an officer, attorney or other person duly authorized to sign the same.
• 1. In order to be valid, this form of proxy together with the power of attorney (if any) or other authority (if any) under which it is signed or a notarially certified copy thereof, must be lodged with the share registrar of the Company in Hong Kong, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong not less than 48 hours (i.e. 9:00 a.m. on Tuesday, June 13, 2023) before the time appointed for holding of the Meeting or the adjourned Meeting (as the case may be).
• 1. In the case of joint holders of shares, any one of such holders may vote at the Meeting, either personally or by proxy, in respect of such shares as if he/she was solely entitled thereto, but if more than one of such joint holders are present at the Meeting personally or by proxy, that one of the said persons so present whose name stands first in the register of members of the Company in respect of such shares shall alone be entitled to vote in respect thereof.
• 1. The proxy needs not be a member of the Company but must attend the Meeting in person to represent you. 9. Completion and return of this form will not preclude you from attending and voting at the Meeting if you so wish. If you attend and vote at the Meeting, the authority of your proxy will be revoked. 10. The full text of the proposed resolutions appears in the notice of the Meeting. PERSONAL INFORMATION COLLECTION STATEMENT

andYouryoursupplyvotingof yourinstructionsand yourforproxy’sthe Meeting(or proxies’)of the name(s)Companyand(theaddress(es)“ Purposes is”). Weon a voluntarymay transferbasisyourfor andthe purposeyour proxy’sof processing(or proxies’)yourname(s)request forandtheaddress(es)appointmentto ourof agent,a proxycontractor,(or proxies)or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorized by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy’s (or proxies’) name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to the Company/Computershare Hong Kong Investor Services Limited at the above address.